Chrysos Corp. Ltd. (AU:C79) has released an update.
Chrysos Corporation Ltd. has announced significant financial growth with a 69% increase in revenue and a 156% rise in EBITDA for FY24, along with the successful deployment of their PhotonAssay technology in various global markets. The company is well-funded for future expansion, with a strong cash position and access to substantial undrawn capital. Looking ahead, Chrysos expects further revenue growth in FY25, projecting an increase to between $60m and $70m.
For further insights into AU:C79 stock, check out TipRanks’ Stock Analysis page.